| Pharmacogenetics of opioids AA Somogyi, DT Barratt, JK Coller Clinical Pharmacology & Therapeutics 81 (3), 429-444, 2007 | 420 | 2007 |
| ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individuals JK Coller, DT Barratt, K Dahlen, MH Loennechen, AA Somogyi Clinical Pharmacology & Therapeutics 80 (6), 682-690, 2006 | 166 | 2006 |
| Persistent postoperative pain after total knee arthroplasty: a prospective cohort study of potential risk factors DA Rice, MT Kluger, PJ McNair, GN Lewis, AA Somogyi, R Borotkanics, ... British journal of anaesthesia 121 (4), 804-812, 2018 | 157 | 2018 |
| Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments DT Barratt, JK Coller, AA Somogyi American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141 …, 2006 | 63 | 2006 |
| ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics DT Barratt, JK Coller, R Hallinan, A Byrne, JM White, DJR Foster, ... Pharmacogenomics and personalized medicine, 53-62, 2012 | 59 | 2012 |
| Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study DT Barratt, B Bandak, P Klepstad, O Dale, S Kaasa, LL Christrup, J Tuke, ... Pharmacogenetics and genomics 24 (4), 185-194, 2014 | 53 | 2014 |
| Pharmacogenetics of opioid response AA Somogyi, JK Coller, DT Barratt Clinical Pharmacology & Therapeutics 97 (2), 125-127, 2015 | 50 | 2015 |
| Pharmacogenomics of methadone maintenance treatment AA Somogyi, DT Barratt, RL Ali, JK Coller Pharmacogenomics 15 (7), 1007-1027, 2014 | 50 | 2014 |
| Innate immune signalling genetics of pain, cognitive dysfunction and sickness symptoms in cancer pain patients treated with transdermal fentanyl DT Barratt, P Klepstad, O Dale, S Kaasa, AA Somogyi PloS one 10 (9), e0137179, 2015 | 33 | 2015 |
| CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose‐adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post‐Kidney … R Hu, DT Barratt, JK Coller, BC Sallustio, AA Somogyi Basic & Clinical Pharmacology & Toxicology 123 (3), 320-326, 2018 | 31 | 2018 |
| Ethnicity-dependent influence of innate immune genetic markers on morphine PCA requirements and adverse effects in postoperative pain AA Somogyi, AT Sia, EC Tan, JK Coller, MR Hutchinson, DT Barratt Pain 157 (11), 2458-2466, 2016 | 31 | 2016 |
| Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal … BC Sallustio, BD Noll, R Hu, DT Barratt, J Tuke, JK Coller, GR Russ, ... British Journal of Clinical Pharmacology 87 (10), 3901-3909, 2021 | 27 | 2021 |
| Corticosterone preexposure increases NF-κB translocation and sensitizes IL-1β responses in BV2 microglia-like cells JJ Liu, S Mustafa, DT Barratt, MR Hutchinson Frontiers in immunology 9, 3, 2018 | 26 | 2018 |
| CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients DT Barratt, HK Cox, A Menelaou, DT Yeung, DL White, TP Hughes, ... Clinical Pharmacokinetics 56, 977-985, 2017 | 25 | 2017 |
| Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib MS Khan, DT Barratt, AA Somogyi Xenobiotica 46 (3), 278-287, 2016 | 25 | 2016 |
| Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesia CV Mulholland, AA Somogyi, DT Barratt, JK Coller, MR Hutchinson, ... Journal of Molecular Neuroscience 52, 497-506, 2014 | 22 | 2014 |
| Harnessing pain heterogeneity and RNA transcriptome to identify blood‐based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic … PM Grace, D Hurley, DT Barratt, A Tsykin, LR Watkins, PE Rolan, ... Journal of neurochemistry 122 (5), 976-994, 2012 | 22 | 2012 |
| High and variable population prevalence of HLA‐B*56:02 in indigenous Australians and relation to phenytoin‐associated drug reaction with eosinophilia and … AA Somogyi, DT Barratt, EJ Phillips, K Moore, F Ilyas, GM Gabb British journal of clinical pharmacology 85 (9), 2163-2169, 2019 | 21 | 2019 |
| Role of pharmacogenetics in personalised imatinib dosing DT Barratt, AA Somogyi Translational Cancer Research 6 (Suppl 10), 2017 | 19 | 2017 |
| Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation R Hu, DT Barratt, JK Coller, BC Sallustio, AA Somogyi Pharmacogenetics and Genomics 29 (1), 9-17, 2019 | 10 | 2019 |
